使用氨甲环酸和微针治疗黄褐斑：系统综述。

IF 2.1 4区医学 Q3 DERMATOLOGY

Cutis Pub Date : 2024-08-01 DOI:10.12788/cutis.1080

Idowu D Olugbade, Nicole A Negbenebor

{"title":"使用氨甲环酸和微针治疗黄褐斑：系统综述。","authors":"Idowu D Olugbade, Nicole A Negbenebor","doi":"10.12788/cutis.1080","DOIUrl":null,"url":null,"abstract":"Melasma is a chronic pigmentary disorder that results in hyperpigmented patches in sun-exposed areas. Tranexamic acid (TXA) and microneedling are potential treatment options for individuals with melasma. The objective of our systematic review was to review 12 randomized controlled trials and clinical trials on the use and efficacy of TXA with microneedling for melasma. The combination of TXA and microneedling was found to be more effective at improving melasma lesions than either treatment alone; TXA alone was equally effective at reducing melasma lesions vs the standard treatment of hydroquinone.","PeriodicalId":11195,"journal":{"name":"Cutis","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Tranexamic Acid and Microneedling in the Treatment of Melasma: A Systematic Review.\",\"authors\":\"Idowu D Olugbade, Nicole A Negbenebor\",\"doi\":\"10.12788/cutis.1080\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Melasma is a chronic pigmentary disorder that results in hyperpigmented patches in sun-exposed areas. Tranexamic acid (TXA) and microneedling are potential treatment options for individuals with melasma. The objective of our systematic review was to review 12 randomized controlled trials and clinical trials on the use and efficacy of TXA with microneedling for melasma. The combination of TXA and microneedling was found to be more effective at improving melasma lesions than either treatment alone; TXA alone was equally effective at reducing melasma lesions vs the standard treatment of hydroquinone.\",\"PeriodicalId\":11195,\"journal\":{\"name\":\"Cutis\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cutis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.12788/cutis.1080\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cutis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12788/cutis.1080","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

黄褐斑是一种慢性色素性疾病，会在暴露于阳光的部位形成色素沉着斑。氨甲环酸（TXA）和微针是治疗黄褐斑的潜在方法。我们的系统性综述旨在回顾 12 项随机对照试验和临床试验，研究氨甲环酸和微针治疗黄褐斑的使用和疗效。研究发现，TXA 和微针疗法相结合比单独使用其中一种疗法更能有效改善黄褐斑病变；单独使用 TXA 与使用氢醌的标准疗法相比，在减少黄褐斑病变方面效果相当。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Use of Tranexamic Acid and Microneedling in the Treatment of Melasma: A Systematic Review.

Melasma is a chronic pigmentary disorder that results in hyperpigmented patches in sun-exposed areas. Tranexamic acid (TXA) and microneedling are potential treatment options for individuals with melasma. The objective of our systematic review was to review 12 randomized controlled trials and clinical trials on the use and efficacy of TXA with microneedling for melasma. The combination of TXA and microneedling was found to be more effective at improving melasma lesions than either treatment alone; TXA alone was equally effective at reducing melasma lesions vs the standard treatment of hydroquinone.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cutis 医学-皮肤病学

CiteScore

1.10

自引率

0.00%

发文量

191

审稿时长

6-12 weeks

期刊介绍： Published since 1965, Cutis is a peer-reviewed clinical journal for the dermatologist, allergist, and general practitioner. The journal is published monthly and focuses on concise clinical articles that present the practical side of dermatology. Referenced in Index Medicus/MEDLINE, it is respected and enjoyed by both specialists and derm-active generalists, enabling its readers to get what they need quickly and efficiently. Furthermore, Cutis is read by more physicians actively involved in the day-to-day treatment of dermatologic conditions than any other dermatology publication. Covering a broad range of pertinent and timely topics, Cutis is written and edited by industry leaders. For information on article submissions, please see our Information for Authors.